| scholarly article | Q13442814 |
| P2093 | author name string | Rachel Gurrell | |
| Mark Whitlock | |||
| Donal Gorman | |||
| Richard P Butt | |||
| Pieter Okkerse | |||
| Geert Jan Groeneveld | |||
| Justin L Hay | |||
| Pinky Dua | |||
| Guido van Amerongen | |||
| Pieter S Siebenga | |||
| P2860 | cites work | Synthesis of lipid mediators during UVB-induced inflammatory hyperalgesia in rats and mice | Q21132412 |
| Pregabalin for acute and chronic pain in adults | Q24239867 | ||
| Further experiments to establish that the analgesic action of aspirin-like drugs depends on the inhibition of prostaglandin biosynthesis | Q24685000 | ||
| Ultraviolet Radiation on the Skin: A Painful Experience? | Q26786606 | ||
| Sex differences in pain: a brief review of clinical and experimental findings | Q26823421 | ||
| Therapeutic Basis of Clinical Pain Modulation | Q28083221 | ||
| Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis | Q28085455 | ||
| Structure and regulation of voltage-gated Ca2+ channels | Q28141138 | ||
| Pain mechanisms: a new theory | Q28251567 | ||
| Effect of hypnotic drugs on body balance and standing steadiness | Q28273740 | ||
| Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors | Q28594296 | ||
| Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAA receptor subtypes in mice | Q30451624 | ||
| Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes | Q30466591 | ||
| Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs | Q34024109 | ||
| Pregabalin in acute and chronic pain | Q34214071 | ||
| Selective distribution of GABA(A) receptor subtypes in mouse spinal dorsal horn neurons and primary afferents | Q34241326 | ||
| The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesia | Q34533554 | ||
| L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors. | Q34574461 | ||
| Evaluation of anti-hyperalgesic and analgesic effects of two benzodiazepines in human experimental pain: a randomized placebo-controlled study | Q34647740 | ||
| Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflamm | Q34827132 | ||
| GABA puts a stop to pain. | Q35972035 | ||
| Sex-specific differences in GABA(A) -benzodiazepine receptor availability: relationship with sensitivity to pain and tobacco smoking craving | Q36044215 | ||
| Peripheral and central mechanisms of cutaneous hyperalgesia | Q36061003 | ||
| Racial and ethnic differences in experimental pain sensitivity: systematic review and meta-analysis. | Q36147231 | ||
| HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain | Q36592958 | ||
| The role of circulating sex hormones in menstrual cycle-dependent modulation of pain-related brain activation | Q36718625 | ||
| Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype | Q36793359 | ||
| Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery | Q37087716 | ||
| The α5 subunit containing GABAA receptors contribute to chronic pain | Q37108088 | ||
| A role for NF-kappaB-dependent gene transactivation in sunburn. | Q37202396 | ||
| Sex-based differences in pain perception and treatment | Q37350598 | ||
| Antihyperalgesia by α2-GABAA receptors occurs via a genuine spinal action and does not involve supraspinal sites | Q37409646 | ||
| Pregabalin in neuropathic pain: evidences and possible mechanisms | Q37559818 | ||
| Descending modulation of pain: the GABA disinhibition hypothesis of analgesia. | Q38234187 | ||
| Glycine receptors and glycine transporters: targets for novel analgesics? | Q38632864 | ||
| Preclinical Assessment of Inflammatory Pain | Q38668522 | ||
| A literature review on the pharmacological sensitivity of human evoked hyperalgesia pain models | Q38839940 | ||
| Efficacy and tolerability of muscle relaxants for low back pain: Systematic review and meta-analysis. | Q38872658 | ||
| An Evidence-Based Review of the Efficacy of Perioperative Analgesic Techniques for Breast Cancer-Related Surgery. | Q38934501 | ||
| The effect of pregabalin on acute postoperative pain in patients undergoing total knee arthroplasty: A meta-analysis | Q38940490 | ||
| Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline | Q38963880 | ||
| Pharmacokinetics and pharmacodynamics of intrathecally administered Xen2174, a synthetic conopeptide with norepinephrine reuptake inhibitor and analgesic properties. | Q39093085 | ||
| Spinal dorsal horn calcium channel alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia | Q39096400 | ||
| The use of baseline covariates in crossover studies | Q39128607 | ||
| Amino acid transmitters in the mammalian central nervous system | Q39874279 | ||
| A Brainstem-Spinal Cord Inhibitory Circuit for Mechanical Pain Modulation by GABA and Enkephalins | Q40349158 | ||
| Psychophysiology of experimentally induced pain | Q40825822 | ||
| Which GABAA-receptor subtypes really occur in the brain? | Q41003268 | ||
| Experimental and procedural pain responses in primary dysmenorrhea: a systematic review | Q42736134 | ||
| Interventions for Neuropathic Pain: An Overview of Systematic Reviews | Q43061660 | ||
| Ethnic differences in cardiovascular-somatosensory interactions and in the central processing of noxious stimuli | Q44960675 | ||
| Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice | Q46193090 | ||
| Pharmacology in translation; the preclinical and early clinical profile of the novel α2/3 functionally selective GABAA receptor positive allosteric modulator PF-06372865. | Q46246232 | ||
| Reversal of pathological pain through specific spinal GABAA receptor subtypes. | Q46803020 | ||
| Mutations affecting glycinergic neurotransmission in hyperekplexia increase pain sensitivity | Q47578725 | ||
| The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover study. | Q47942829 | ||
| Demonstration of an anti-hyperalgesic effect of a novel pan-Trk inhibitor PF-06273340 in a battery of human evoked pain models. | Q48232122 | ||
| Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist. | Q48306835 | ||
| Antihyperalgesic effect of the GABA(A) ligand clobazam in a neuropathic pain model in mice: a pharmacokinetic-pharmacodynamic study | Q48365122 | ||
| GABAergic modulation of diffuse noxious inhibitory controls (DNIC): a test by use of lorazepam | Q48480686 | ||
| Alpha5GABAA receptors mediate the amnestic but not sedative-hypnotic effects of the general anesthetic etomidate. | Q48592383 | ||
| Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. | Q51434685 | ||
| Effect profile of paracetamol, Δ9-THC and promethazine using an evoked pain test battery in healthy subjects. | Q52595793 | ||
| GABAergic modulation in central sensitization in humans | Q60684340 | ||
| Expression of GABA(A) receptor alpha5 subunit-like immunoreactivity in human hippocampus | Q73093479 | ||
| NS11821, a partial subtype-selective GABAA agonist, elicits selective effects on the central nervous system in randomized controlled trial with healthy subjects | Q86886419 | ||
| No evidence of potentiation of buprenorphine by milnacipran in healthy subjects using a nociceptive test battery | Q88374096 | ||
| A randomised, placebo-controlled clinical trial with the α2/3/5 subunit selective GABAA positive allosteric modulator PF-06372865 in patients with chronic low back pain | Q88771965 | ||
| P433 | issue | 2 | |
| P304 | page(s) | e194-e203 | |
| P577 | publication date | 2019-01-31 | |
| P1433 | published in | British Journal of Anaesthesia | Q72466 |
| P1476 | title | Analgesic potential of PF-06372865, an α2/α3/α5 subtype-selective GABAA partial agonist, in humans | |
| P478 | volume | 123 |
Search more.